Sign up now with your company or organization email and enjoy a
1-week free trial!
Contract Awards
Total
22
contracts found.
22
contracts are listing.
Advanced Filters
Deliveries of Special Medical Material for Intervention Cardiology Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
28.03.2022
Medicinal Products Containing Active Substituzumab Emtansin Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
31.01.2022
Medicinal Products Containing Active Ingredients Ribociclib-succinate Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
31.01.2022
Medicinal Products Containing Active Ingredients Pazopanib-hydrochloride Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
31.01.2022
Medicinal Products Containing Active Substance Enzalutamide Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing the Active Ingredient Palbociklib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing Active Substance Evolokumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing Active Ingredient Panitumumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing Active Substance Vedolizumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Ingredients Oxacilin Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Substance Kobozantinib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Substance Ustekinumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Ingredient Dabrafenib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredients Tocilizumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Substance Trametinib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredients Eltrombopag Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredients Ibroutinib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredients Tocilizumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021